kkr: Four brands made JB Chemicals a prize catch for KKR. Next, the PE firm needs to belt out new hits.

JB Chemicals and Pharmaceuticals, a relatively reserved drug maker, has come into the limelight, with global private-equity (PE) firm KKR set to acquire a 54% stake in the company at INR745 per share. This will trigger an open offer for another 26% stake, but KKR will cap its overall holding at 64.9%. Until a year ago, PE firms buying controlling stakes in Indian pharma companies was unheard of. But in the last few months, the JB Chemicals-KKR